RE:SESN valuation is proof positive TLT is wildly under-valuednewdaydawning wrote
Disgraced biotech Sesen is still valued @ US$196M or roughly five times more than TLT's CDN$49M.
Something is terribly wrong with this picture, given Sesen unethical behavior and the FDA's rejection of its trial therapy for NMIBC.
Sesen' loss is potentially TLT's gain. Would love to see the market-cap gap close to give a true sense of Theralase's value.
Good comparison newdaydawning and to look at another company that has skyrocketed on potential high future earnings lets look back at what happened to GameStop (GME) went from $6 to a high of $483 (now at 199) and in my opinion Theralase with success in NMIBC and probable continued achievements in lung & brain cancer treatments will easily top GameStop's high of $483. Profits from each cancer indications are what will drive share price to E.P. multiples of greater than 80X again in my biased opinion.